Neurological Genetics tests in Dubai & UAE

Compare available Neurological Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,000.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetics test prices

Showing 1–15 of 71 matching tests.

Neurological Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5674 AP4E1 Gene SPG51 Genetic Test This test screens for pathogenic variants in the AP4E1 gene associated with hereditary spastic paraplegia type 51 (SPG51).	Peripheral Whole Blood (EDTA) or Saliva	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AP4E1 gene", "Full exon and splice-site analysis"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent bone marrow transplant"] Indications ["Suspected hereditary spastic paraplegia type 51 (SPG51)", "Family history of SPG51"] Measurement technique Confirm with laboratory Codes LOINC: 94486-1 ICD-10: G11.4 Clinical summary This test screens for pathogenic variants in the AP4E1 gene associated with hereditary spastic paraplegia type 51 (SPG51).
TEST-3772 APOE Genotyping (Alzheimer's Disease Type 2) Genetic Test This genetic test identifies the APOE genotype (ε2/ε3/ε4), assessing an individual's genetic predisposition to late-onset Alzheimer's disease.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["APOE ε2 allele", "APOE ε3 allele", "APOE ε4 allele"] Parameters [] Preparation ["Mandatory pre-test genetic counselling required"] Indications ["Assessment of genetic risk for late-onset Alzheimer's disease", "Personalized preventive planning based on genetic risk"] Measurement technique Confirm with laboratory Codes LOINC: 48818-7 ICD-10: Z13.858 Clinical summary This genetic test identifies the APOE genotype (ε2/ε3/ε4), assessing an individual's genetic predisposition to late-onset Alzheimer's disease.
TEST-4347 ARHGEF9 Gene (Early Infantile Epileptic Encephalopathy Type 8) NGS Test This test identifies pathogenic variants in the ARHGEF9 gene associated with Early Infantile Epileptic Encephalopathy Type 8 (EIEE8).	Whole Blood (EDTA) or FTA Card	21–28 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in ARHGEF9 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed prior to sample collection"] Indications ["Suspected Early Infantile Epileptic Encephalopathy Type 8 (EIEE8)", "Unexplained severe early-onset seizures", "Developmental delay with seizures"] Measurement technique Confirm with laboratory Codes LOINC: 103735-4 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants in the ARHGEF9 gene associated with Early Infantile Epileptic Encephalopathy Type 8 (EIEE8).
TEST-5804 ARSI Gene SPG66 Genetic Test This test analyzes the ARSI gene for pathogenic variants associated with hereditary spastic paraplegia type 66 (SPG66). It utilizes Next-Generation Sequencing (NGS) for high sensit...	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARSI gene sequence", "Pathogenic variants in ARSI gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Suspected hereditary spastic paraplegia type 66", "Family history of SPG66", "Neurological symptoms consistent with SPG66"] Measurement technique Confirm with laboratory Codes LOINC: 95836-5 ICD-10: G11.4 Clinical summary This test analyzes the ARSI gene for pathogenic variants associated with hereditary spastic paraplegia type 66 (SPG66). It utilizes Next-Generation Sequencing (NGS) for high sensitivity and specificity.
TEST-5655 ATL1 Gene (SPG3A) Next‑Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants in the ATL1 gene associated with autosomal dominant hereditary spastic paraplegia type 3A (SPG3A).	Peripheral whole blood, extracted DNA, or DNA FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATL1 gene", "Coverage of coding and deep intronic regions"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected hereditary spastic paraplegia type 3A", "Family history of SPG3A"] Measurement technique Confirm with laboratory Codes LOINC: 21656-8 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the ATL1 gene associated with autosomal dominant hereditary spastic paraplegia type 3A (SPG3A).
TEST-5478 ATL1 Gene Neuropathy, Hereditary Sensory, Type 1D Genetic Test This genetic test analyzes the ATL1 gene to identify mutations associated with Hereditary Sensory Neuropathy Type 1D (HSN1D). It detects single nucleotide variants, insertions, del...	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATL1 gene sequence", "Mutations in ATL1 gene (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "No specific medication or diet restrictions"] Indications ["Clinical suspicion of Hereditary Sensory Neuropathy Type 1D (HSN1D)", "Family history of HSN1D"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G60.8 Clinical summary This genetic test analyzes the ATL1 gene to identify mutations associated with Hereditary Sensory Neuropathy Type 1D (HSN1D). It detects single nucleotide variants, insertions, deletions, and copy number variations within the gene.
TEST-5787 BEAN1 Gene Spinocerebellar Ataxia Type 31 (SCA31) Genetic Test This genetic test detects pathogenic repeat expansions and variants in the BEAN1 gene associated with Spinocerebellar Ataxia Type 31 (SCA31).	Whole blood (EDTA), extracted DNA, or FTA card (dried blood spot)	3–4 weeks from sample collection	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic pentanucleotide repeat expansions in the BEAN1 gene", "Other pathogenic variants in the BEAN1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected diagnosis of SCA31 based on clinical presentation", "Family history of SCA31", "Need for definitive diagnosis for management and genetic counseling", "Pre-symptomatic or predictive testing in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G11.0 Clinical summary This genetic test detects pathogenic repeat expansions and variants in the BEAN1 gene associated with Spinocerebellar Ataxia Type 31 (SCA31).
TEST-4490 CASK Gene (FG Syndrome Type 4) Genetic Test This test evaluates the CASK gene for mutations associated with FG syndrome type 4, an X-linked neurodevelopmental disorder.	Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CASK gene coding region", "CASK gene splice sites"] Parameters [] Preparation ["No special preparation such as fasting is required.", "Stay well hydrated before the appointment."] Indications ["Suspected FG syndrome type 4", "X-linked neurodevelopmental disorder investigation"] Measurement technique Confirm with laboratory Codes LOINC: 90268-4 ICD-10: Q87.8 Clinical summary This test evaluates the CASK gene for mutations associated with FG syndrome type 4, an X-linked neurodevelopmental disorder.
TEST-4530 CCDC88C Gene Hydrocephalus, Nonsyndromic, Autosomal Recessive Type 1 Genetic Test This test identifies pathogenic variants in the CCDC88C gene associated with nonsyndromic, autosomal recessive hydrocephalus type 1.	Peripheral whole blood (EDTA) or FTA card	15–21 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCDC88C gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist about anticoagulant therapy"] Indications ["Suspected autosomal recessive hydrocephalus type 1", "Family history of hydrocephalus"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q03.8 Clinical summary This test identifies pathogenic variants in the CCDC88C gene associated with nonsyndromic, autosomal recessive hydrocephalus type 1.
TEST-5483 CCT5 Gene Neuropathy (Hereditary Sensory with Spastic Paraplegia) Genetic Test This genetic test evaluates the CCT5 gene for pathogenic variants associated with hereditary sensory neuropathy with spastic paraplegia.	Peripheral whole blood, DNA, or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCT5 gene", "Full coding region analysis"] Parameters [] Preparation [] Indications ["Diagnosis of hereditary sensory neuropathy with spastic paraplegia", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 91553-4 ICD-10: G60.8 Clinical summary This genetic test evaluates the CCT5 gene for pathogenic variants associated with hereditary sensory neuropathy with spastic paraplegia.
TEST-5550 CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test This test detects pathogenic mutations in the CERS1 gene associated with Progressive Myoclonus Epilepsy Type 8.	Whole blood (2–5 ml in EDTA tube) or FTA card	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CERS1 gene"] Parameters [] Preparation ["No fasting required", "No medication adjustments needed", "Pre-test genetic counseling is mandatory"] Indications ["Suspected diagnosis of Progressive Myoclonus Epilepsy Type 8", "Family history of PME8", "Need for genetic confirmation for treatment planning"] Measurement technique Confirm with laboratory Codes LOINC: 53832-6 ICD-10: G40.3 Clinical summary This test detects pathogenic mutations in the CERS1 gene associated with Progressive Myoclonus Epilepsy Type 8.
TEST-4449 CHD2 Gene Epileptic Encephalopathy, Childhood‑Onset Genetic Test This genetic test identifies pathogenic variants in the CHD2 gene associated with childhood-onset epileptic encephalopathy.	Whole blood (peripheral), extracted DNA, or FTA card spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHD2 gene", "Coverage of entire coding region + 20 bp exon-intron boundaries"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Children with suspected CHD2-related epileptic encephalopathy", "Early-onset seizures with developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 82324-3 ICD-10: G40.4, G40.9, G31.9 Clinical summary This genetic test identifies pathogenic variants in the CHD2 gene associated with childhood-onset epileptic encephalopathy.
TEST-3892 CHD8 Gene Autism Susceptibility Type 18 Genetic Test This genetic test identifies pathogenic variants within the CHD8 gene, which are associated with specific forms of autism spectrum disorder.	Peripheral whole blood (EDTA) or saliva (Oragene DNA collection kit)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHD8 gene"] Parameters [] Preparation [] Indications ["Confirmed autism diagnosis", "Unexplained developmental delay", "Intellectual disability", "Documented family history suggestive of CHD8-related neurodevelopmental conditions"] Measurement technique Confirm with laboratory Codes LOINC: 82320-4 ICD-10: F84.0 Clinical summary This genetic test identifies pathogenic variants within the CHD8 gene, which are associated with specific forms of autism spectrum disorder.
TEST-4367 CHRNA4 Gene Epilepsy, Nocturnal Frontal Lobe Type 1 Genetic Test This test identifies pathogenic variants in the CHRNA4 gene associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).	Peripheral Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHRNA4 gene", "Deletions and duplications in the CHRNA4 gene"] Parameters [] Preparation [] Indications ["Suspected Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)", "Family history of ADNFLE", "Need for genetic counselling and family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G40.0 Clinical summary This test identifies pathogenic variants in the CHRNA4 gene associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).
TEST-4325 COLQ Gene Endplate Acetylcholinesterase Deficiency Genetic Test This genetic test detects pathogenic variants in the COLQ gene associated with endplate acetylcholinesterase deficiency, a cause of congenital myasthenic syndrome.	Peripheral Whole Blood (EDTA), Extracted Genomic DNA, or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COLQ gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during acute illness"] Indications ["Suspected congenital myasthenic syndrome (CMS)", "Family history of CMS", "Need for definitive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 90218-5 ICD-10: G70.2 Clinical summary This genetic test detects pathogenic variants in the COLQ gene associated with endplate acetylcholinesterase deficiency, a cause of congenital myasthenic syndrome.

Category overview

Neurological Genetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurological Genetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurological genetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.